2-1. Osteoporose. Dr. P. Van Wettere Radiologie en medische beeldvorming

Size: px
Start display at page:

Download "2-1. Osteoporose. Dr. P. Van Wettere Radiologie en medische beeldvorming"

Transcription

1 2-1 Osteoporose Dr. P. Van Wettere Radiologie en medische beeldvorming

2 2-2 Osteoporose Definitie Incidentie, mortaliteit, morbiditeit, kost Diagnose Radiologie Botdensitometrie FRAX

3 FractureCascade History Asymptomatic in the prefracture phase 2-3

4 Prevent Vertebral Fracture Cascade 2-4 B/L 10YR 20YR

5 2-5 Definition of Osteoporosis A disease characterized by low bone mass and microarchitectural deterioration of bone tissue leading to enhanced bone fragility and a consequent increase in fracture risk. World Health Organization (WHO), 1994 Normal bone Osteoporosis

6 Pathogenesis of Osteoporotic Fracture 2-6 Low peak bone mass Postmenopausal Bone loss Age related bone loss LOW BONE MASS Other risk factors Non skeletal factors (propensity to fall) FRACTURE = Fall + Low BMD Poor bone quality (architecture) LOW BMD = PBM or Loss Adapted from Melton LJ & Riggs BL. Osteoporosis: Etiology, Diagnosis and Management Raven Press, 1988, pp

7 2-7 Determinants of Peak Bone Mass Genetics Nutrition PEAK BONE MASS years of age Hormones Lifestyle

8 2-8 OSTEOPOROSIS: THE SIZE OF THE PROBLEM

9 2-9 Osteoporosis is a Prevalent Disease Affects 200 million women worldwide 1-1/3 of women aged 60 to 70-2/3 of women aged 80 or older Approximately 20-25% of women over the age of 50 have one or more vertebral fractures 2 - United States: 25% 3 - Australia: 20% 4 - Western Europe: 19% 5 - Scandinavia: 26% 5 - Denmark: 21% 6 1. International Osteoporosis Foundation 4. Jones G et al., Osteoporos Int 1996, 6: Melton LJ 3rd et al., Spine 1997, 22:2S 5. O'Neill et al., J Bone Miner Res 1996, 11: Ettinger B et al., J Bone Miner Res 1992,7: Jensen GF et al., Clin Orthop 1982,166:75

10 2-10 Vertebral Fractures Most common fracture type Often silent Insidious, progressive nature Associated with deformity, height loss, back pain impaired breathing increased morbidity and mortality Predict future spine and hip fractures

11 Incidence Rates for Vertebral, Wrist & Hip Fractures in Women after Age Annual incidence per 1000 women Vertebrae Hip Wrist Age (Years) Wasnich RD, Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. 4th edition, 1999

12 2-12 Osteoporotic Fracture Incidence 4,000 Women Men Incidence / 100,000 Person-Years 3,000 2,000 1,000 Vertebrae Hip Vertebrae Hip Forearm Forearm Age (Years) Cooper C. et al, Trends Endocrinol Metab 1992; 3:224

13 Incidence United States) of Osteoporotic Fractures ( Only 30% of morphometric vertebral fractures are clinically apparent 2-13 Annual Incidence 750, , , ,000 Clinically apparent 300, , , Vertebral (Morphometric) Hip Wrist Fracture Type Other

14 Osteoporotic Fractures in Women: Comparison with Other Diseases 2-14 Annual incidence x * hip forearm other sites vertebral * annual incidence all ages annual estimate women 29+ annual estimate women new cases, all ages Osteoporotic Fractures Heart Attack Stroke Breast Cancer Riggs BL, Melton LJ. Bone 1995 Heart and Stroke Facts, 1996, American Heart Association Cancer Facts & Figures, 1996, American Cancer Society

15 Projected Burden of Osteoporotic Hip Fractures Worldwide 2-15 Estimated number hip fractures (x1000) Total no. hip fractures 1990 = 1.66 million 2050 = 6.26 million 0 North America Europe Latin America Asia Adapted from Cooper C., Melton LJ, Osteoporos Int 1992, 2:285

16 Projected Number of Osteoporotic Hip Fractures Worldwide Projected to reach million in Asia by Total number of hip fractures: 1950 = 1.66 million 2050 = 6.26 million Estimated number of hip fractures: (1000s) Adapted from C. Cooper et al, Osteoporos Int. 1992; 2:285-9

17 OSTEOPOROSIS: MORTALITY & MORBIDITY 2-17

18 Cumulative Survival Probability WOMEN 1.0 MEN Survival probability Survival probability Age Age Center JR et al., Lancet 1999, 353:878 Dubbo Population Vertebral/Major Fractures Proximal Femur Fractures

19 Mortality Rates by Number of Prevalent Vertebral Fractures Mortality (per 1000 person-years) Number of Vertebral Fractures Kado DM et al., Arch Intern Med 1999,159:1215 P for trend < 0.001

20 Relative Risk of Death Following Clinical Fractures 2-20 Fracture Intervention Trial (FIT)* Any Symptomatic Non-spine Hip Spine Forearm Other Age-Adjusted Relative Risk (95% CI) *6459 postmenopau sal women ages years followed for an average of 3.8 years Cauley JA et al., Osteoporos Int 2000, 11:556

21 Clinical Consequences 2-21 Kyphosis Loss of height Bulging abdomen Acute and chronic pain Breathing difficulties, reflux and other GI symptoms Depression REDUCED QUALITY OF LIFE

22 2-22 Vertebral Fractures Substantially Increase the Risk of New Fragility Fractures Women with vertebral fractures have a 5-fold increased risk of a new vertebral fracture and a 2-fold increased risk of hip fracture Black et al., J Bone Miner Res 1999 Melton et al, Osteoporos Int 1999 One woman in five will suffer from another vertebral fracture within a year Lindsay et al., JAMA, 2001

23 2-23 High Rate of Repeat Fractures % of Patients Fracturing Again within 1 Year Multiple 20% of women with new vert fx will re-fracture within one year Number of Spine Fractures at Start of Year Lindsay, 2000

24 Effect of Prior Vertebral Fracture on Risk of Subsequent Vertebral Fracture 2-24 Incidence of New Vertebral Fracture (%) RR=5.1 (3.1, 8.4) RR=2.6 (1.4, 4.9) RR=7.3 (4.4, 12.3) First Year of Study 2725 postmenopausal women randomised to placebo No. of Vertebral Fractures at Baseline Adapted from Lindsay R et al., JAMA 2001, 285:320

25 2-25 Vertebral Fractures in Summary Are the most common osteoporotic fractures Are associated with excess mortality Are associated with significant morbidity, even if they do not come to clinical attention Increase the risk of subsequent vertebral fracture(s) by 5 fold and of other fragility fractures (including hip) by 2 fold

26 2-26 Hip Fracture Impact on Life Quality 61 % of hip fractures occur at home 100 % hospitalized 82 % referred to rehabilitation clinic One year after hospitalization: 65 % live at home 17 % deceased 18 % need nursing Schürch M. et al, J. Bone Miner Res 1996; 12:

27 COST OF OSTEOPOROSIS 2-27

28 2-28 Some Costs of Osteoporosis in Europe In Europe the total direct costs of osteoporotic fractures are over 31 billion and are expected to increase to more that 76 billion in Kanis JA & Johnell O. - Osteoporos Int 2005 (in press) In France osteoporotic hip fractures are estimated to cost about 1 billion every year* In Spain the total direct hospital cost of osteoporotic fractures in 1995 was approximately 222 million* In England & Wales the total direct hospital cost of osteoporotic fractures in 1999 was approximately 847 million* *Osteoporosis in the European Community: A Call to Action. IOF Nov, 2001

29 Osteoporosis Results in More Disability & Direct Hospital Cost Than Many Other Diseases % of vertebral fractures are hospitalised and 2% require long-term nursing care Ross et al., Am Journal of Medicine 1997, 103(2A):30S 42S Annual cost of acute hospitalisation in Switzerland in 1992: 600 million Swiss francs (US$350 million) Lippuner et al., Osteoporosis Int 1997, 7: Number of bed days (men & women) 891,000 for COPD 701,000 for osteoporosis 533,000 for stroke 328,000 for myocardial infarction 201,000 for breast cancer Osteoporosis # 1 when looking at women only

30 2-30 UNDER-DIAGNOSIS OF VERTEBRAL FRACTURES: WHAT IS THE SIZE OF THE PROBLEM? Look for it!!

31 2-31 Unrecognized Vertebral Fractures On X-Ray women age 60 and older, hospitalized for various reasons Chest x-rays reviewed for fracture Number of Subjects % 40 23% 17% 20 7% 0 Fracture Present Mentioned in Report Mentioned in Summary Osteoporosis in Med Record Treatment for Osteoporosis Gehlbach SH et al, Osteoporos Int 2000;11:

32 2-32 High Prevalence of Vertebral Deformities 80 Prevalence of Deformities* (%) Melton, Age (yrs) 25% of women over age 50 have Vertebral Deformities

33 2-33 A Large Prospective Study Demonstrates Under- Diagnosis of Vertebral Fractures is a Worldwide Problem Vertebral fractures were markedly under-diagnosed in radiology reports in a multicenter, multinational study population of osteoporotic women (n=2451) in which 789 (32%) women had 1 vertebral fracture at baseline. Adjudicated discrepancies (n=350) between local and central readings due to undetected vertebral fracture (68%) or equivocal terminology in the local radiology report (32%) yielded a false-negative rate of 34%. Under-diagnosis of vertebral fractures was observed in all geographic regions (false-negative rates: North America 45.2%, Latin America 46.5%, Europe/South Africa/Australia 29.5%). The false-positive rate was 5% globally. Under-diagnosis of vertebral fracture is a worldwide problem attributable in part to a lack of radiographic detection or use of ambiguous terminology in the radiology report, or both. Delmas et al., J Bone Miner Res 2005, in press.

34 Background 2-34 Worldwide, a substantial percentage of vertebral fractures are not diagnosed by radiologists or clinicians It is likely that this contributes to unnecessary pain and suffering and to the under treatment of osteoporosis Identification of patients with a vertebral fracture is important because the presence of prevalent fracture greatly increases the risk of future fracture Recent widespread approval of effective treatments for patients with osteoporotic vertebral fractures

35 2-35 Problem: Vertebral Fracture Assessment by Radiologists Vertebral Fractures are: Not being identified Not being reported Not being acted upon

36 2-36 Are Physicians Treating Osteoporosis after Hip Fracture Center I II III IV n DXA 12% 12% 13% 24% Ca-Suppl. 27% 1% 3% 25% Estrogens 10% 6% 0% 14% Alendronate 8% 2% 4% 10% Calcitonin 11% 0% 0% 14% Raloxifene 0.1% 0% 1% 6% Total Treatment 29.1% 8% 5% 37% Harrington J. et al, Arthritis & Rheum. 2002; 47:651

37 2-37 Treatment of Osteoporosis Are Physicians Missing an Opportunity? 1162 women with a distal radial fracture, > 55yrs (60% < 74yrs) 2.8% had a bone-density scan (in 80% Osteoporosis found) 22.9% were treated with at least one medication (estrogen, bisphosphonates, calcitonin) 76% received neither a bone-density scan nor medical treatment of osteoporosis Freedman K. et al, J. Bone and Joint Surg 2000; 82-A:

38 2-38 When to Consider X-Ray Exam Clinical suspicion of vertebral fracture Pain Kyphosis Loss of height

Osteoporosis and Vertebral Compression (Spinal) Fractures Fact Sheet

Osteoporosis and Vertebral Compression (Spinal) Fractures Fact Sheet Osteoporosis and Vertebral Compression (Spinal) Fractures Fact Sheet About Osteoporosis Osteoporosis is estimated to affect 200 million women worldwide. 1 Worldwide, osteoporosis causes more than nine

More information

Fast Facts on Osteoporosis

Fast Facts on Osteoporosis Fast Facts on Osteoporosis Definition Prevalence Osteoporosis, or porous bone, is a disease characterized by low bone mass and structural deterioration of bone tissue, leading to bone fragility and an

More information

Osteoporosis Assessment Using DXA and Instant Vertebral Assessment. Working Together For A Healthier Community

Osteoporosis Assessment Using DXA and Instant Vertebral Assessment. Working Together For A Healthier Community Osteoporosis Assessment Using DXA and Instant Vertebral Assessment Working Together For A Healthier Community Osteoporosis The Silent Thief The Facts About Osteoporosis 1 in 2 women will develop osteoporosis

More information

Osteoporosis/Bone Health in Adults as a National Public Health Priority

Osteoporosis/Bone Health in Adults as a National Public Health Priority Position Statement Osteoporosis/Bone Health in Adults as a National Public Health Priority This Position Statement was developed as an educational tool based on the opinion of the authors. It is not a

More information

Module 5 - Speaking of Bones Osteoporosis For Health Professionals: Fracture Risk Assessment. William D. Leslie, MD MSc FRCPC

Module 5 - Speaking of Bones Osteoporosis For Health Professionals: Fracture Risk Assessment. William D. Leslie, MD MSc FRCPC Module 5 - Speaking of Bones Osteoporosis For Health Professionals: Fracture Risk Assessment William D. Leslie, MD MSc FRCPC Case #1 Age 53: 3 years post-menopause Has always enjoyed excellent health with

More information

PRACTICAL DENSITOMETRY

PRACTICAL DENSITOMETRY PRACTICAL DENSITOMETRY The Challenge of Osteoporosis Osteoporosis is a silent disease that develops over decades Goal: identify patients with osteoporosis before fractures occur Means: measure bone density

More information

Osteoporosis has been identified by the US Surgeon General

Osteoporosis has been identified by the US Surgeon General New Guidelines for the Prevention and Treatment of Osteoporosis E. Michael Lewiecki, MD, and Nelson B. Watts, MD Abstract: The World Health Organization Fracture Risk Assessment Tool (FRAX ) and the National

More information

16. ARTHRITIS, OSTEOPOROSIS, AND CHRONIC BACK CONDITIONS

16. ARTHRITIS, OSTEOPOROSIS, AND CHRONIC BACK CONDITIONS 16. ARTHRITIS, OSTEOPOROSIS, AND CHRONIC BACK CONDITIONS Goal Reduce the impact of several major musculoskeletal conditions by reducing the occurrence, impairment, functional limitations, and limitation

More information

Clinical Policy Guideline

Clinical Policy Guideline Clinical Policy Guideline Policy Title: Bone Density Testing Policy No: B0215A.00 Effective Date: 01/01/15 Date Reviewed: 03/25/15 I. DEFINITION/BACKGROUND Bone density testing is used to estimate the

More information

Recent Topics in Treatment of Osteoporosis

Recent Topics in Treatment of Osteoporosis Review Article Recent Topics in Treatment of Osteoporosis JMAJ 49(9 10): 309 314, 2006 Satoshi Soen* 1 Abstract It has come to light that osteoporosis-related fractures are more critical than previously

More information

FRAX Identifying people at high risk of fracture

FRAX Identifying people at high risk of fracture FRAX Identifying people at high risk of fracture WHO Fracture Risk Assessment Tool, a new clinical tool for informed treatment decisions Authored by Dr. Eugene McCloskey International Osteoporosis Foundation

More information

Bone Basics National Osteoporosis Foundation 2013

Bone Basics National Osteoporosis Foundation 2013 When you have osteoporosis, your bones become weak and are more likely to break (fracture). You can have osteoporosis without any symptoms. Because it can be prevented and treated, an early diagnosis is

More information

Epidemiology, costs and burden of osteoporosis in Mexico

Epidemiology, costs and burden of osteoporosis in Mexico DOI 10.1007/s11657-010-0042-8 REVIEW Epidemiology, costs and burden of osteoporosis in Mexico Patricia Clark Fernando Carlos José Luis Vázquez Martínez Received: 16 April 2010 /Accepted: 28 June 2010 #

More information

Falls and Fracture Risk assessment and management

Falls and Fracture Risk assessment and management Falls and Fracture Risk assessment and management Disclosures: Although various guidelines and studies were reviewed, this represents my own personal bias and conclusions. What do we know? 1) Fractures

More information

Osteoporosis Update. Laura E. Ryan, MD

Osteoporosis Update. Laura E. Ryan, MD Osteoporosis Update Laura E. Ryan, MD Assistant Director for Special Programs Center for Women s Health Clinical Assistant Professor of Medicine Division of Endocrinology, Diabetes and Metabolism The Ohio

More information

Press Information. Vitamin D deficiency

Press Information. Vitamin D deficiency DSM, Corporate Communications P.O. Box 6500, 6401 HJ Heerlen The Netherlands phone +31 (0) 45 578 2421 www.dsm.com Vitamin D is one of the essential nutrients for human health. Unlike other types of vitamins

More information

Orthopaedic Issues in Adults with CP: If I Knew Then, What I Know Now

Orthopaedic Issues in Adults with CP: If I Knew Then, What I Know Now Orthopaedic Issues in Adults with CP: If I Knew Then, What I Know Now Laura L. Tosi, MD Director, Bone Health Program Children s National Medical Center Washington, DC Epidemiology 87-93% of children born

More information

Osteoporosis: The patient s perspective. Claire Severgnini Chief Executive

Osteoporosis: The patient s perspective. Claire Severgnini Chief Executive Osteoporosis: The patient s perspective Claire Severgnini Chief Executive 1 Osteoporosis A long-term condition, mainly affecting people in later life Bones are fragile and more likely to fracture easily

More information

Bone Densitometry. What is a Bone Density Scan (DXA)?

Bone Densitometry. What is a Bone Density Scan (DXA)? Scan for mobile link. Bone Densitometry Bone densitometry, also called dual-energy x-ray absorptiometry or DEXA, uses a very small dose of ionizing radiation to produce pictures of the inside of the body

More information

How To Choose A Biologic Drug

How To Choose A Biologic Drug North Carolina Rheumatology Association Position Statements I. Biologic Agents A. Appropriate delivery, handling, storage and administration of biologic agents B. Indications for biologic agents II. III.

More information

Compliance with drug therapies for the treatment and prevention of osteoporosis

Compliance with drug therapies for the treatment and prevention of osteoporosis Maturitas 48 (2004) 271 287 Compliance with drug therapies for the treatment and prevention of osteoporosis Jeffrey S. McCombs a,, Patrick Thiebaud b, Connie McLaughlin-Miley c, Jinhai Shi c a Department

More information

Drug treatment pathway for Osteoporosis in Postmenopausal Women

Drug treatment pathway for Osteoporosis in Postmenopausal Women Drug treatment pathway for Osteoporosis in Postmenopausal Women Version 1.0 Ratified by: East Sussex HEMC Date ratified: 26.01.2011 Job title of originator/author Gillian Ells, East Sussex HEMC Pharmacist

More information

PROTOCOL FOR PATIENTS WITH ABNORMAL LAB AND X-RAY VALUES

PROTOCOL FOR PATIENTS WITH ABNORMAL LAB AND X-RAY VALUES PROTOCOL FOR PATIENTS WITH ABNORMAL LAB AND X-RAY VALUES Patients newly diagnosed as osteopenic or osteoporotic on a radiology report or patients receiving abnormal lab values on the following lab tests

More information

X-Plain Vertebral Compression Fractures Reference Summary

X-Plain Vertebral Compression Fractures Reference Summary X-Plain Vertebral Compression Fractures Reference Summary Introduction Back pain caused by a vertebral compression fracture, or VCF, is a common condition that affects thousands of people every year. A

More information

The Women s Health Initiative: The Role of Hormonal Therapy in Disease Prevention

The Women s Health Initiative: The Role of Hormonal Therapy in Disease Prevention The Women s Health Initiative: The Role of Hormonal Therapy in Disease Prevention Robert B. Wallace, MD, MSc Departments of Epidemiology and Internal Medicine University of Iowa College of Public Health

More information

What You Need to Know for Better Bone Health

What You Need to Know for Better Bone Health What You Need to Know for Better Bone Health A quick lesson about bones: Why healthy bones matter The healthier your bones The more active you can be Bone health has a major effect on your quality of life

More information

Measure Title X RAY PRIOR TO MRI OR CAT SCAN IN THE EVAULATION OF LOWER BACK PAIN Disease State Back pain Indicator Classification Utilization

Measure Title X RAY PRIOR TO MRI OR CAT SCAN IN THE EVAULATION OF LOWER BACK PAIN Disease State Back pain Indicator Classification Utilization Client HMSA: PQSR 2009 Measure Title X RAY PRIOR TO MRI OR CAT SCAN IN THE EVAULATION OF LOWER BACK PAIN Disease State Back pain Indicator Classification Utilization Strength of Recommendation Organizations

More information

If you were diagnosed with cancer today, what would your chances of survival be?

If you were diagnosed with cancer today, what would your chances of survival be? Q.1 If you were diagnosed with cancer today, what would your chances of survival be? Ongoing medical research from the last two decades has seen the cancer survival rate increase by more than 40%. However

More information

CMAJ JAMC. 2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada

CMAJ JAMC. 2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada CANADIAN M EDICAL A SSOCIATION J OURNAL J OURNAL DE L ASSOCIATION MÉDICALE CANADIENNE CMAJ JAMC 2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada CMAJ 2002;167(10

More information

Service delivery interventions

Service delivery interventions Service delivery interventions S A S H A S H E P P E R D D E P A R T M E N T O F P U B L I C H E A L T H, U N I V E R S I T Y O F O X F O R D CO- C O O R D I N A T I N G E D I T O R C O C H R A N E E P

More information

Osteoporosis. The inside looks like honeycomb, with blood vessels and bone marrow in the spaces between bone.

Osteoporosis. The inside looks like honeycomb, with blood vessels and bone marrow in the spaces between bone. Osteoporosis The bones in our skeleton are made of a thick outer shell and a strong inner mesh filled with collagen (protein), calcium salts and other minerals. Osteoporosis The inside looks like honeycomb,

More information

SPINAL FRACTURES OUR TREATMENT GUIDE

SPINAL FRACTURES OUR TREATMENT GUIDE SPINAL FRACTURES OUR TREATMENT GUIDE 7 Cervical Spinal fractures are common around the world and can have a major impact on your quality of life. If not treated soon enough, they can even make carrying

More information

NATIONAL OSTEOPOROSIS FOUNDATION OSTEOPOROSIS CLINICAL UPDATES Rehabilitation of Patients With Fragility-Related Fractures CE APPLICATION FORM

NATIONAL OSTEOPOROSIS FOUNDATION OSTEOPOROSIS CLINICAL UPDATES Rehabilitation of Patients With Fragility-Related Fractures CE APPLICATION FORM NATIONAL OSTEOPOROSIS FOUNDATION OSTEOPOROSIS CLINICAL UPDATES Rehabilitation of Patients With Fragility-Related Fractures CE APPLICATION FORM First Name: Last Name: Mailing Address: City: State: Zip/Postal

More information

Clinical guideline for the prevention and treatment of osteoporosis in postmenopausal women and older men

Clinical guideline for the prevention and treatment of osteoporosis in postmenopausal women and older men Clinical guideline for the prevention and treatment of osteoporosis in postmenopausal women and older men February 2010 Approved by NHMRC on 5 February 2010 The Royal Australian College of General Practitioners,

More information

A Treatment Algorithm for Indian Patients of Osteoporosis

A Treatment Algorithm for Indian Patients of Osteoporosis Indian Medical Gazette FEBRUARY 2012 67 Symposia Update A Treatment Algorithm for Indian Patients of Osteoporosis Shailendra Mohan Lakhotia, Senior Consultant Orthopedic Surgeon, Kolkata 700 045. Prashant

More information

DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) OSTEOPOROSIS GUIDELINE

DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) OSTEOPOROSIS GUIDELINE DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) OSTEOPOROSIS GUIDELINE This is an updated guideline It incorporates the latest NICE guidance There are strong recommendations for calcium + vitamin D

More information

Osteoporosis Diagnosis: BMD, FRAX and Assessment of Secondary Osteoporosis. Disclosure and Conflicts of Interest Steven T Harris MD 2014-2015

Osteoporosis Diagnosis: BMD, FRAX and Assessment of Secondary Osteoporosis. Disclosure and Conflicts of Interest Steven T Harris MD 2014-2015 Osteoporosis Diagnosis: BMD, FRAX and Assessment of Secondary Osteoporosis Steven T Harris MD FACP Clinical Professor of Medicine University of California, San Francisco steve.harris@ucsf.edu Disclosure

More information

Hormone therapy and breast cancer: conflicting evidence. Cindy Farquhar Cochrane Menstrual Disorders and Subfertility Group

Hormone therapy and breast cancer: conflicting evidence. Cindy Farquhar Cochrane Menstrual Disorders and Subfertility Group Hormone therapy and breast cancer: conflicting evidence Cindy Farquhar Cochrane Menstrual Disorders and Subfertility Group The world of hormone therapy in the 1990 s Throughout the 1970s, 1980s and 1990s

More information

DEFINITION OF OSTEOPOROSIS

DEFINITION OF OSTEOPOROSIS CHAPTER 27 OSTEOPOROSIS AND OSTEOMALACIA DEFINITION OF OSTEOPOROSIS THE EPIDEMIOLOGY AND CONSEQUENCES OF OSTEOPOROSIS REVIEW OF BONE REMODELING BONE LOSS PATHOGENESIS OF OSTEOPOROSIS DIAGNOSIS OF OSTEOPOROSIS

More information

HEALTH CARE COSTS 11

HEALTH CARE COSTS 11 2 Health Care Costs Chronic health problems account for a substantial part of health care costs. Annually, three diseases, cardiovascular disease (including stroke), cancer, and diabetes, make up about

More information

BONE MINERAL DENSITOMETRY REPORTING

BONE MINERAL DENSITOMETRY REPORTING CAR TECHNICAL STANDARDS FOR BONE MINERAL DENSITOMETRY REPORTING APPROVED: JANUARY 25, 2013 KERRY SIMINOSKI, MD, FRCPC; MARGARET O'KEEFFE, MD, FRCPC; JACQUES P. BROWN, MD, FRCPC; STEVEN BURRELL, MD, FRCPC;

More information

Treatment of osteoporosis in fragility fractures

Treatment of osteoporosis in fragility fractures Orthogeriatrics Clinical Summary Document Treatment of osteoporosis in fragility fractures Fragility fractures are extremely prevalent in older adults with a staggering cost of treatment. As the population

More information

COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) GUIDELINE ON THE EVALUATION OF MEDICINAL PRODUCTS IN THE TREATMENT OF PRIMARY OSTEOPOROSIS

COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) GUIDELINE ON THE EVALUATION OF MEDICINAL PRODUCTS IN THE TREATMENT OF PRIMARY OSTEOPOROSIS European Medicines Agency London, 16 November 2006 Doc. Ref. CPMP/EWP/552/95 Rev. 2 COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) GUIDELINE ON THE EVALUATION OF MEDICINAL PRODUCTS IN THE TREATMENT

More information

Barriers to Osteoporosis Identification and Treatment Among Primary Care Physicians and Orthopedic Surgeons

Barriers to Osteoporosis Identification and Treatment Among Primary Care Physicians and Orthopedic Surgeons 334 Original Article Barriers to Osteoporosis Identification and Treatment Among Primary Care Physicians and Orthopedic Surgeons CHRISTINE SIMONELLI, MD; KATHLEEN KILLEEN, MOT; SUSAN MEHLE, BS; AND LEAH

More information

Stickler Syndrome and Arthritis

Stickler Syndrome and Arthritis Stickler Syndrome and Arthritis Arthritis Foundation Pacific Region, Nevada Office Presented by: Crystal Schulz, MPH Community Development Manager Arthritis Foundation Improving lives through leadership

More information

Osteoporosis International. Original Article. The Cost of Treating Osteoporotic Fractures in the United Kingdom Female Population

Osteoporosis International. Original Article. The Cost of Treating Osteoporotic Fractures in the United Kingdom Female Population Osteoporos Int (1998) 8:611 617 ß 1998 European Foundation for Osteoporosis and the National Osteoporosis Foundation Osteoporosis International Original Article The Cost of Treating Osteoporotic Fractures

More information

Health Benchmarks Program Clinical Quality Indicator Specification 2013

Health Benchmarks Program Clinical Quality Indicator Specification 2013 Health Benchmarks Program Clinical Quality Indicator Specification 2013 Measure Title USE OF IMAGING STUDIES FOR LOW BACK PAIN Disease State Musculoskeletal Indicator Classification Utilization Strength

More information

November 2014. 3. This submission focuses on the following areas:

November 2014. 3. This submission focuses on the following areas: November 2014 Arthritis Research UK response: Centre for Policy on Ageing and Local Government Association call for evidence on local government s response to an ageing society 1. Arthritis Research UK

More information

Loss of hip bone mineral density over time is associated with spine and hip fracture incidence in osteoporotic postmenopausal women

Loss of hip bone mineral density over time is associated with spine and hip fracture incidence in osteoporotic postmenopausal women Eur J Epidemiol (2009) 24:707 712 DOI 10.1007/s10654-009-9381-4 LOCOMOTOR DISEASES Loss of hip bone mineral density over time is associated with spine and hip fracture incidence in osteoporotic postmenopausal

More information

Bone Mineral Density Studies

Bone Mineral Density Studies Bone Mineral Density Studies Policy Number: 6.01.01 Last Review: 5/2015 Origination: 10/1988 Next Review: 5/2016 Policy Blue Cross and Blue Shield of Kansas City (Blue KC) will provide coverage for bone

More information

Clinical Practice Guidelines for the Diagnosis and Management of Osteoporosis in Canada: Background and Technical Report

Clinical Practice Guidelines for the Diagnosis and Management of Osteoporosis in Canada: Background and Technical Report Clinical Practice Guidelines for the Diagnosis and Management of Osteoporosis in Canada: Background and Technical Report Authors: Alexandra Papaioannou MD MSc 1, Suzanne Morin MD MSc 2, Angela M. Cheung

More information

The Effect of Alendronate on the Age-Specific Incidence of Symptomatic Osteoporotic. Fractures. Maastricht 6

The Effect of Alendronate on the Age-Specific Incidence of Symptomatic Osteoporotic. Fractures. Maastricht 6 Revised Manuscript The Effect of Alendronate on the Age-Specific Incidence of Symptomatic Osteoporotic Fractures Marc C. Hochberg 1, Desmond E. Thompson 2, Dennis M. Black 3, Sara A. Quandt 4, Jane Cauley

More information

BULLETIN. Slovak Republic Ministry of Health

BULLETIN. Slovak Republic Ministry of Health BULLETIN Slovak Republic Ministry of Health Part 51-53 November 13, 2009 No. 57 CONTENTS: 52. Slovak Republic Ministry of Health Guidelines for the Diagnosis of Glucocorticoidinduced Osteoporosis 52. Slovak

More information

European guidance for the diagnosis and management of osteoporosis in postmenopausal women

European guidance for the diagnosis and management of osteoporosis in postmenopausal women DOI 10.1007/s00198-012-2074-y POSITION PAPER European guidance for the diagnosis and management of osteoporosis in postmenopausal women J. A. Kanis & E. V. McCloskey & H. Johansson & C. Cooper & R. Rizzoli

More information

Osteoarthritis and osteoporosis

Osteoarthritis and osteoporosis Osteoarthritis and osteoporosis What is osteoporosis? Osteoporosis occurs when the struts which make up the mesh-like structure within bones become thin causing them to become fragile and break easily,

More information

Psoriasis Co-morbidities: Changing Clinical Practice. Theresa Schroeder Devere, MD Assistant Professor, OHSU Dermatology. Psoriatic Arthritis

Psoriasis Co-morbidities: Changing Clinical Practice. Theresa Schroeder Devere, MD Assistant Professor, OHSU Dermatology. Psoriatic Arthritis Psoriasis Co-morbidities: Changing Clinical Practice Theresa Schroeder Devere, MD Assistant Professor, OHSU Dermatology Psoriatic Arthritis Psoriatic Arthritis! 11-31% of patients with psoriasis have psoriatic

More information

Epidemiology, Staging and Treatment of Lung Cancer. Mark A. Socinski, MD

Epidemiology, Staging and Treatment of Lung Cancer. Mark A. Socinski, MD Epidemiology, Staging and Treatment of Lung Cancer Mark A. Socinski, MD Associate Professor of Medicine Multidisciplinary Thoracic Oncology Program Lineberger Comprehensive Cancer Center University of

More information

Role of Dual-Energy X-Ray Absorptiometry in the Diagnosis and Treatment of Osteoporosis

Role of Dual-Energy X-Ray Absorptiometry in the Diagnosis and Treatment of Osteoporosis Journal of Clinical Densitometry, vol. 10, no. 1, 102e110, 2007 Ó Copyright 2007 by The International Society for Clinical Densitometry 1094-6950/07/10:102e110/$32.00 DOI: 10.1016/j.jocd.2006.11.001 Review

More information

Performance of Osteoporosis Risk Assessment Tools in Iranian Postmenopausal Women

Performance of Osteoporosis Risk Assessment Tools in Iranian Postmenopausal Women Int J Endocrinol Metab 2007; 1: 26-32 Performance of Osteoporosis Risk Assessment Tools in Iranian Postmenopausal Women ORIGINAL ARTICLE Dabbaghmanesh MH a, Sabet R b, Aria A a, R Omrani GR a aendocrine

More information

Care pathways for vertebral compression fractures

Care pathways for vertebral compression fractures Care pathways for vertebral compression fractures SYDNEY MEDICAL SCHOOL Associate Professor Manuela L Ferreira, PhD Sydney Medical Foundation Fellow Institute of Bone and Joint Research and The George

More information

Client Sex Facility Birth Date Height Weight Measured Sample Client Male (not specified) 00/00/0000 72.0 in. 180.0 lbs. 02/20/2016

Client Sex Facility Birth Date Height Weight Measured Sample Client Male (not specified) 00/00/0000 72.0 in. 180.0 lbs. 02/20/2016 SUMMARY RESULTS This table provides an overview of your total body composition, broken down into total body fat %, total mass, fat tissue, lean tissue, and bone mineral content. These metrics establish

More information

The WHI 12 Years Later: What Have We Learned about Postmenopausal HRT?

The WHI 12 Years Later: What Have We Learned about Postmenopausal HRT? AACE 23 rd Annual Scientific and Clinical Congress (2014) Syllabus Materials: The WHI 12 Years Later: What Have We Learned about Postmenopausal HRT? JoAnn E. Manson, MD, DrPH, FACP, FACE Chief, Division

More information

OSTEOPOROSIS OROR OR. Towards a Fracture-Free Future

OSTEOPOROSIS OROR OR. Towards a Fracture-Free Future OSTEOPOROSIS OROR OR Towards a Fracture-Free Future March, 2011 Patients with fragility fractures are at the highest risk of developing new fractures. Interventions can reduce that risk! 1 Executive Summary

More information

Cost Effectiveness Estimate of Bazedoxifene

Cost Effectiveness Estimate of Bazedoxifene Article ID: WMC002547 2046-1690 Cost Effectiveness Estimate of Bazedoxifene Corresponding Author: Dr. Ana A Iglesias, pharmacist, Pharmacy Department - Hospital of Manacor - Spain Submitting Author: Dr.

More information

OSTEOPOROSIS REHABILITATION PROGRAM

OSTEOPOROSIS REHABILITATION PROGRAM OSTEOPOROSIS REHABILITATION PROGRAM Tricia Orme, R.N. BSc(N) Mary Pack Arthritis Program Victoria i Arthritis i Centre Objectives Participants will gain an understanding of what Osteoporosis is and how

More information

Us TOO University Presents: Estrogen Deficiency Side Effects Due to Androgen Deprivation Therapy

Us TOO University Presents: Estrogen Deficiency Side Effects Due to Androgen Deprivation Therapy Us TOO University Presents: Estrogen Deficiency Side Effects Due to Androgen Deprivation Therapy Today s speaker is Samir Taneja, MD Program moderator is Pam Barrett, Us TOO International Made possible

More information

Type 1 Diabetes ( Juvenile Diabetes)

Type 1 Diabetes ( Juvenile Diabetes) Type 1 Diabetes W ( Juvenile Diabetes) hat is Type 1 Diabetes? Type 1 diabetes, also known as juvenile-onset diabetes, is one of the three main forms of diabetes affecting millions of people worldwide.

More information

(212) 733-2324 mackay.jimeson@pfizer.com

(212) 733-2324 mackay.jimeson@pfizer.com For immediate release: July 9, 2012 Media Contacts: MacKay Jimeson (212) 733-2324 mackay.jimeson@pfizer.com Pfizer Recognizes 10 th Anniversary Of The Women s Health Initiative: A Modern Day Perspective

More information

ASSESSMENT OF OSTEOPOROSIS AT THE PRIMARY HEALTH CARE LEVEL

ASSESSMENT OF OSTEOPOROSIS AT THE PRIMARY HEALTH CARE LEVEL WHO Scientific Group Technical Report ASSESSMENT OF OSTEOPOROSIS AT THE PRIMARY HEALTH CARE LEVEL Reference Kanis JA on behalf of the World Health Organization Scientific Group (2007) Assessment of osteoporosis

More information

Osteoporosis. Dr Gordon MacDonald BSc MB BChir MRCP Consultant Rheumatologist. Rheumatology and Arthritis Seminar Tuesday 5 th February 2013

Osteoporosis. Dr Gordon MacDonald BSc MB BChir MRCP Consultant Rheumatologist. Rheumatology and Arthritis Seminar Tuesday 5 th February 2013 Osteoporosis Dr Gordon MacDonald BSc MB BChir MRCP Consultant Rheumatologist Rheumatology and Arthritis Seminar Tuesday 5 th February 2013 Plan What is osteoporosis? Consequences of osteoporosis Risk factors

More information

Hormone Restoration: Is It Right for You? Patricia A. Stafford, M.D. Founder, Wellness ReSolutions

Hormone Restoration: Is It Right for You? Patricia A. Stafford, M.D. Founder, Wellness ReSolutions Hormone Restoration: Is It Right for You? Patricia A. Stafford, M.D. Founder, Wellness ReSolutions IMPORTANCE OF HORMONE BALANCE Importance of Hormone Balance Help you live a long, healthy life Help you

More information

Does chronic lymphocytic leukemia increase the risk of osteoporosis?

Does chronic lymphocytic leukemia increase the risk of osteoporosis? Does chronic lymphocytic leukemia increase the risk of osteoporosis? Amrita Desai, MD Internal Medicine Residency Program Adam Olszewski, MD Department of Hematology and Oncology Memorial Hospital of Rhode

More information

OST and BMD Risk Assessment in Morocco

OST and BMD Risk Assessment in Morocco DOI 10.1007/s10067-007-0611-4 ORIGINAL ARTICLE Performance of the osteoporosis risk assessment tool in Moroccan men Mirieme Ghazi & Aziza Mounach & Abderrazak Nouijai & Imad Ghozlani & Loubna Bennani &

More information

BISPHOSPHONATE RELATED OSTEONECROSIS OF THE JAW (BRONJ) BISPHOSPHONATES AND WHAT HAPPENS TO BONE VINCENT E. DIFABIO, DDS, MS MEMBER OF THE COMMITTEE ON HEALTHCARE AND ADVOCACY FROM THE AMERICAN ASSOCIATION

More information

25-hydroxyvitamin D: from bone and mineral to general health marker

25-hydroxyvitamin D: from bone and mineral to general health marker DIABETES 25 OH Vitamin D TOTAL Assay 25-hydroxyvitamin D: from bone and mineral to general health marker FOR OUTSIDE THE US AND CANADA ONLY Vitamin D Receptors Brain Heart Breast Colon Pancreas Prostate

More information

Measure #41: Osteoporosis: Pharmacologic Therapy for Men and Women Aged 50 Years and Older National Quality Strategy Domain: Effective Clinical Care

Measure #41: Osteoporosis: Pharmacologic Therapy for Men and Women Aged 50 Years and Older National Quality Strategy Domain: Effective Clinical Care Measure #41: Osteoporosis: Pharmacologic Therapy for Men and Women Aged 50 Years and Older National Quality Strategy Domain: Effective Clinical Care 2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS, REGISTRY

More information

GUIDELINES FOR ASSESSMENT OF SPINAL STABILITY THE CHRISTIE, GREATER MANCHESTER & CHESHIRE. CP57 Version: V3

GUIDELINES FOR ASSESSMENT OF SPINAL STABILITY THE CHRISTIE, GREATER MANCHESTER & CHESHIRE. CP57 Version: V3 GUIDELINES FOR ASSESSMENT OF SPINAL STABILITY THE CHRISTIE, GREATER MANCHESTER & CHESHIRE Procedure Reference: Document Owner: CP57 Version: V3 Dr V. Misra Accountable Committee: Acute Oncology Group Network

More information

Osteoporosis in elderly: prevention and treatment

Osteoporosis in elderly: prevention and treatment Clin Geriatr Med 18 (2002) 529 555 Osteoporosis in elderly: prevention and treatment Manish Srivastava, MD a, Chad Deal, MD b, * a Section of Geriatric Medicine, A91 Cleveland Clinic Foundation, 9500 Euclid

More information

CAPTURE THE FRACTURE A GLOBAL CAMPAIGN TO BREAK THE FRAGILITY FRACTURE CYCLE. www.iofbonehealth.org

CAPTURE THE FRACTURE A GLOBAL CAMPAIGN TO BREAK THE FRAGILITY FRACTURE CYCLE. www.iofbonehealth.org CAPTURE THE FRACTURE A GLOBAL CAMPAIGN TO BREAK THE FRAGILITY FRACTURE CYCLE www.iofbonehealth.org normal bone osteoporotic bone WHAT IS OSTEOPOROSIS? Osteoporosis is a disease characterized by low bone

More information

Testosterone; What s all the hype? KRISTEN WYRICK, LTCOL,USAFR, MC USUHS, FAMILY MEDICINE JOINT BASE LANGLEY-EUSTIS

Testosterone; What s all the hype? KRISTEN WYRICK, LTCOL,USAFR, MC USUHS, FAMILY MEDICINE JOINT BASE LANGLEY-EUSTIS Testosterone; What s all the hype? KRISTEN WYRICK, LTCOL,USAFR, MC USUHS, FAMILY MEDICINE JOINT BASE LANGLEY-EUSTIS The faces of Low Testosterone What your patients are seeing Pharmacy Industry Testosterone

More information

Healthy Aging Lab: Current Research Abstracts

Healthy Aging Lab: Current Research Abstracts Healthy Aging Lab: Current Research Abstracts Arsenic Exposure and Women s Health Environmental exposure to inorganic arsenic is an indisputable source of increased risk of several human cancers and chronic

More information

Medications for Prevention and Treatment of Osteoporosis

Medications for Prevention and Treatment of Osteoporosis 1 Medications for Prevention and Treatment of Osteoporosis Osteoporosis is a disease where the strength of bones is less than normal, making them more susceptible to fracture, or breaking, than normal

More information

Bone Densitometry and the Treatment of Osteoporosis

Bone Densitometry and the Treatment of Osteoporosis Reference Section Bone Densitometry and the Treatment of steoporosis a report by Dr Glen Blake and Professor Ignac Fogelman Senior Lecturer, and Professor of Nuclear Medicine, Guy s, King s and St Thomas

More information

How To Take A Bone Marrow Transplant

How To Take A Bone Marrow Transplant Drug treatments to protect your bones This information is an extract from the booklet, Bone health. You may find the full booklet helpful. We can send you a copy free see page 5. Contents Bisphosphonates

More information

PCHC FACTS ABOUT HEALTH CONDITIONS AND MOOD DIFFICULTIES

PCHC FACTS ABOUT HEALTH CONDITIONS AND MOOD DIFFICULTIES PCHC FACTS ABOUT HEALTH CONDITIONS AND MOOD DIFFICULTIES Why should mood difficulties in individuals with a health condition be addressed? Many people with health conditions also experience mood difficulties

More information

Scans and tests and osteoporosis

Scans and tests and osteoporosis Scans and tests and osteoporosis What is osteoporosis? Osteoporosis occurs when the struts which make up the mesh-like structure within bones become thin causing them to become fragile and break easily,

More information

WOMENCARE A Healthy Woman is a Powerful Woman (407) 898-1500. Hormone Therapy

WOMENCARE A Healthy Woman is a Powerful Woman (407) 898-1500. Hormone Therapy Hormone Therapy WOMENCARE A Healthy Woman is a Powerful Woman (407) 898-1500 At menopause, a woman's body makes less estrogen and she stops having menstrual periods. This is a natural stage in a woman's

More information

Sam Berman Dr. Kim Ferguson Samantha Dalby NP

Sam Berman Dr. Kim Ferguson Samantha Dalby NP Sam Berman Dr. Kim Ferguson Samantha Dalby NP CE LHIN Total population = 1,463,801 Estimated Family Physician shortage of 55 110 Unattached patient estimate of 86,000 Purpose was to provide unattached

More information

Osteoporosis International. Original Article. Calcium Supplement and Bone Medication Use in a US Medicare Health Maintenance Organization

Osteoporosis International. Original Article. Calcium Supplement and Bone Medication Use in a US Medicare Health Maintenance Organization Osteoporos Int (2002) 13:657 662 ß 2002 International Osteoporosis Foundation and National Osteoporosis Foundation Osteoporosis International Original Article Calcium Supplement and Bone Medication Use

More information

Osteoporosis is a common and costly systemic disease

Osteoporosis is a common and costly systemic disease OUTCOMES IN PRACTICE Osteoporosis Disease Management: Best Practices from the Penn State Geisinger Health System Eric D. Newman, MD, Ralph H. Starkey, MD, William T. Ayoub, MD, FACP, FACR, Charles M. Davis

More information

Medications to Prevent and Treat Osteoporosis

Medications to Prevent and Treat Osteoporosis Medications to Prevent and Treat Osteoporosis National Institutes of Health Osteoporosis and Related Bone Diseases ~ National Resource Center 2 AMS Circle Bethesda, MD 20892-3676 Tel: (800) 624-BONE or

More information

THE INTERNET STROKE CENTER PRESENTATIONS AND DISCUSSIONS ON STROKE MANAGEMENT

THE INTERNET STROKE CENTER PRESENTATIONS AND DISCUSSIONS ON STROKE MANAGEMENT THE INTERNET STROKE CENTER PRESENTATIONS AND DISCUSSIONS ON STROKE MANAGEMENT Stroke Prevention in Atrial Fibrillation Gregory Albers, M.D. Director Stanford Stroke Center Professor of Neurology and Neurological

More information

Drug treatments for osteoporosis

Drug treatments for osteoporosis Drug treatments for osteoporosis What is osteoporosis? Osteoporosis occurs when the struts which make up the mesh-like structure within bones become thin causing them to become fragile and break easily,

More information

Screening Mammography for Breast Cancer: American College of Preventive Medicine Practice Policy Statement

Screening Mammography for Breast Cancer: American College of Preventive Medicine Practice Policy Statement Screening Mammography for Breast Cancer: American College of Preventive Medicine Practice Policy Statement Rebecca Ferrini, MD, Elizabeth Mannino, MD, Edith Ramsdell, MD and Linda Hill, MD, MPH Burden

More information

QCT BMD Imaging vs DEXA BMD Imaging

QCT BMD Imaging vs DEXA BMD Imaging QCT BMD Imaging vs DEXA BMD Imaging by Charles (Chuck) Maack Prostate Cancer Advocate Wichita, Kansas Chapter, Us TOO Intl., Inc. Dual-Energy X-ray Absorptiometry (DEXA) or Quantitative Computerized Tomography

More information

Bone Markers in Osteoporosis: Prediction of Fractures & Treatment Monitoring

Bone Markers in Osteoporosis: Prediction of Fractures & Treatment Monitoring Bone Markers in Osteoporosis: Prediction of Fractures & Treatment Monitoring Richard Eastell, MD FRCP FRCPath FMedSci, Professor of Bone Metabolism, University of Sheffield, Sheffield, UK Usefulness of

More information

Margaret French, Specialist Nurse, Fracture Liaison Service Glasgow Royal Infirmary Rachel Lewis Rheumatology Specialist Physiotherapist, North

Margaret French, Specialist Nurse, Fracture Liaison Service Glasgow Royal Infirmary Rachel Lewis Rheumatology Specialist Physiotherapist, North Margaret French, Specialist Nurse, Fracture Liaison Service Glasgow Royal Infirmary Rachel Lewis Rheumatology Specialist Physiotherapist, North Bristol NHS Trust Very informal workshop to facilitate discussion

More information

Low-dose CT Imaging. Edgar Fearnow, M.D. Section Chief, Computed Tomography, Lancaster General Hospital

Low-dose CT Imaging. Edgar Fearnow, M.D. Section Chief, Computed Tomography, Lancaster General Hospital Lung Cancer Screening with Low-dose CT Imaging Edgar Fearnow, M.D. Section Chief, Computed Tomography, Lancaster General Hospital Despite recent declines in the incidence of lung cancer related to the

More information

Osteoporotic fracture risk assessment

Osteoporotic fracture risk assessment steoporotic fracture risk assessment de 24 29/08/2011 13:50 Official reprint from UpToDate www.uptodate.com 2011 UpToDate Osteoporotic fracture risk assessment Author E Michael Lewiecki, MD Disclosures

More information

Requests. Who requests a DXA scan? DXA. DXA Technology. Adequate Clinical Information

Requests. Who requests a DXA scan? DXA. DXA Technology. Adequate Clinical Information Requests Define a protocol for validation and prioritisation of densitometry requests. Registered medical practitioners In writing Include adequate clinical information Unsuitable requests should be discussed

More information